Clinical Trial: A Study in Healthy People to Measure How Different Doses of Verducatib Affect the Heart

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07760246) titled 'A Study in Healthy People to Measure How Different Doses of Verducatib Affect the Heart' on Aug. 07.

Brief Summary: The main objective of this trial is to evaluate the effects of verducatib in the range of therapeutic to supra-therapeutic exposures on the QT/QTc-interval and other ECG parameters

Study Start Date: Aug. 17

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Verducatib

Verducatib

DRUG: Moxifloxacin

Moxifloxacin

DRUG: Placebo resembling Verducatib

Placebo resembling Verducatib

DRUG: Placebo resembling Moxifloxacin

Placebo resembling Moxifloxacin

Recruitment Status: NOT_YET_RECRUITING

Sponsor...